K. Komuta

725 total citations
19 papers, 579 citations indexed

About

K. Komuta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, K. Komuta has authored 19 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in K. Komuta's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (4 papers). K. Komuta is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (4 papers). K. Komuta collaborates with scholars based in Japan. K. Komuta's co-authors include K. Maeda, Ryo Kimura, Soichiro Yokota, Seigo Minami, Takashi Yamasaki, Kengo Takeuchi, Masahiko Tsujimoto, Yasushi Sakamaki, Masahiko Ito and Ichiro Yamaguchi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

K. Komuta

17 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Komuta Japan	9	287	225	148	144	97	19	579
Yasuaki Takeyama Japan	13	203 0.7×	48 0.2×	268 1.8×	52 0.4×	80 0.8×	67	617
Shingo Usui∥ Japan	14	173 0.6×	138 0.6×	208 1.4×	19 0.1×	95 1.0×	30	599
Masao Ichiki Japan	15	369 1.3×	273 1.2×	112 0.8×	19 0.1×	196 2.0×	47	622
Myla Lai-Goldman United States	10	255 0.9×	94 0.4×	84 0.6×	30 0.2×	146 1.5×	14	473
Ezequiel Neimark United States	10	368 1.3×	173 0.8×	288 1.9×	48 0.3×	89 0.9×	50	926
Jianguo Shao China	16	86 0.3×	66 0.3×	282 1.9×	54 0.4×	249 2.6×	43	720
Sören Weidemann Germany	12	88 0.3×	92 0.4×	191 1.3×	30 0.2×	117 1.2×	37	501
Shigeki Yokomuro Japan	16	241 0.8×	199 0.9×	262 1.8×	29 0.2×	272 2.8×	49	1.1k
Jean Pierre Benhamou France	11	135 0.5×	53 0.2×	859 5.8×	102 0.7×	49 0.5×	13	1.3k
Barbara J. Brennan United States	13	139 0.5×	42 0.2×	164 1.1×	50 0.3×	100 1.0×	41	530

Countries citing papers authored by K. Komuta

Since Specialization

Citations

This map shows the geographic impact of K. Komuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Komuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Komuta more than expected).

Fields of papers citing papers by K. Komuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Komuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Komuta. The network helps show where K. Komuta may publish in the future.

Co-authorship network of co-authors of K. Komuta

This figure shows the co-authorship network connecting the top 25 collaborators of K. Komuta. A scholar is included among the top collaborators of K. Komuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Komuta. K. Komuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kimura, Masashi, Kazumi Nishino, Yukihiro Yano, et al.. (2019). P2.16-19 Real World Data in Non-Small Cell Lung Cancer with Activating EGFR Mutation - A Multicenter Observational Study. Journal of Thoracic Oncology. 14(10). S872–S873.

Koyama, Ryo, Hibiki Udagawa, Eri Sugiyama, et al.. (2018). Randomized phase II study comparing cisplatin + pemetrexed + bevacizumab with carboplatin + paclitaxel + bevacizumab in treatment-naïve advanced non-squamous non-small cell lung cancer (CLEAR study). Annals of Oncology. 29. viii518–viii518. 3 indexed citations

Nishijima, Yoshinori, et al.. (2015). Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 2 indexed citations

Nishino, Kazumi, Fumio Imamura, Satoshi Morita, et al.. (2013). A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment. Lung Cancer. 82(2). 299–304. 22 indexed citations

Kijima, Takashi, Takayuki Shiroyama, K. Komuta, et al.. (2012). Phase II Study of S-1 Monotherapy with Application of Dose-Adjustment by Creatinine Clearance in Chemonaive Elderly Patients with Advanced Non-Small-Cell Lung Cancer. Annals of Oncology. 23. xi115–xi115.

Namba, Yoshinobu, Fumio Imamura, Satoshi Morita, et al.. (2012). Does Gefitinib Re-challenge or Treatment Beyond Progression (TBP) Prolong Survival of NSCLC Patients? - Real World Evidence from Gefitinib Treatment Responders. Annals of Oncology. 23. ix411–ix411. 2 indexed citations

Yamasaki, Takashi, Seigo Minami, K. Komuta, et al.. (2010). Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma. Journal of Clinical Pathology. 63(12). 1066–1070. 111 indexed citations

Kawahara, Mutsuto, K. Komuta, Hiroshige Yoshioka, et al.. (2010). Randomized phase II study of carboplatin plus either docetaxel (CbD) or paclitaxel (CbP) in Japanese patients with advanced non-small cell lung cancer (NSCLC): JMTO LC07-01.. Journal of Clinical Oncology. 28(15_suppl). e18069–e18069. 1 indexed citations

Kawahara, Mutsuto, Satoshi Teramukai, Kaoru Kubota, et al.. (2009). Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03. British Journal of Cancer. 101(9). 1537–1542. 69 indexed citations

10.

Kawahara, Mutsuto, Mitsumasa Ogawara, Yutaka Nishiwaki, et al.. (2006). Phase III randomized study of vinorelbine (V), gemcitabine (G) followed by docetaxel (D) (VGD) versus paclitaxel (P) and carboplatin (C) (PC) in patients (pts) with advanced non-small cell lung cancer (NSCLC) (Japan Multinational Trial Organization LC00–03). Journal of Clinical Oncology. 24(18_suppl). 7013–7013. 5 indexed citations

11.

Kudoh, Satoshi, Satoaki Nakamura, Takashi Nakano, et al.. (2005). Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group. Lung Cancer. 49(2). 263–269. 11 indexed citations

12.

Hosoe, S, K. Komuta, Kazuhiko Shibata, et al.. (2003). Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02). British Journal of Cancer. 88(3). 342–347. 16 indexed citations

13.

Ohno, Masako, Ichiro Yamaguchi, Tomoaki Fukuda, et al.. (2000). Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.. PubMed. 4(3). 256–61. 188 indexed citations

14.

Asai, Mitsutoshi, et al.. (2000). [Improvement in quality of life with vinorelbine as a single agent in two patients with recurrent lung cancer].. PubMed. 27(13). 2105–8. 1 indexed citations

15.

Kudoh, Satoshi, Satoko Nakamura, K. Komuta, et al.. (2000). Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC). Lung Cancer. 29(1). 41–41. 4 indexed citations

16.

Maeda, K., et al.. (1997). Cyclosporine Treatment for Polymyositis/Dermatomyositis: Is it Possible to Rescue the Deteriorating Cases with Interstitial Pneumonitis?. Scandinavian Journal of Rheumatology. 26(1). 24–29. 77 indexed citations

17.

Nakano, Takashi, Harumichi Ikegami, Shôji Nakamura, et al.. (1996). A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. British Journal of Cancer. 73(9). 1096–1100. 2 indexed citations

18.

Kawase, Ichiro, K. Komuta, Hideki Hara, et al.. (1988). Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.. PubMed. 48(5). 1173–9. 39 indexed citations

19.

Masuno, Tomiya, et al.. (1987). Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer. Lung Cancer. 3(1). 29–30. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact